Cargando…
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis
Emerging data have suggested that circulating tumor DNA (ctDNA) can be a reliable biomarker for minimal residual disease (MRD) in CRC patients. Recent studies have shown that the ability to detect MRD using ctDNA assay after curative-intent surgery will change how to assess the recurrence risk and p...
Autores principales: | Chidharla, Anusha, Rapoport, Eliot, Agarwal, Kriti, Madala, Samragnyi, Linares, Brenda, Sun, Weijing, Chakrabarti, Sakti, Kasi, Anup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298915/ https://www.ncbi.nlm.nih.gov/pubmed/37373376 http://dx.doi.org/10.3390/ijms241210230 |
Ejemplares similares
-
Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)
por: Chakrabarti, Sakti, et al.
Publicado: (2022) -
A case of cardiac sarcoidosis with concurrent myocardial ischemia
por: Rapoport, Eliot A., et al.
Publicado: (2021) -
Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis
por: Park, Robin, et al.
Publicado: (2020) -
Coinfection of Helicobacter pylori and Hepatitis C Virus in the Development of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Madala, Samragnyi, et al.
Publicado: (2021) -
Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience
por: Al-Jumayli, Mohammed, et al.
Publicado: (2019)